Lyra Therapeutics (LYRA) Announces Appointment of Robert Kern, MD, as Chief Medical Officer
- S&P 500 closes higher to secure strongest Q1 since 2019
- UBS sees 5 warnings signals on semiconductor chip stocks
- US consumer sentiment tops estimates in March to hit nearly 3-yr high, UMich says
- Reddit (RDDT) stock continues to slide as short-sellers eye stock
- Estée Lauder (EL) climbs as BofA upgrades to Buy on profit recovery expectations
- AMC Entertainment (AMC) enters into an equity distribution agreement
- Kerrisdale Capital is short Microstrategy (MSTR), long bitcoin
- AMC Entertainment (AMC) Enters $250M ATM Agreement
- Intuitive Machines (LUNR) Files for $300M Share Offering, 160M Share Offering by Selling Stockholders
- Home Depot (HD) to Acquire SRS Distribution for $18.25B EV
Lyra Therapeutics Announces Appointment of Robert Kern, MD, as Chief Medical Officer
February 17, 2021 8:00 AM ESTThought leader in the ENT treatment community brings insight from clinical practice to next stage of development for LYR-210 and pipeline
WATERTOWN, Mass.--(BUSINESS WIRE)-- Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and... More